MML Investors Services’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,139
| Closed | -$164K | – | 2715 |
|
|
2024
Q4 | $164K | Buy |
+17,139
| New | +$164K | ﹤0.01% | 2557 |
|
|
2022
Q1 | – | Sell |
-4,826
| Closed | -$210K | – | 2077 |
|
|
2021
Q4 | $210K | Sell |
4,826
-1,922
| -28% | -$83.6K | ﹤0.01% | 1901 |
|
|
2021
Q3 | $338K | Buy |
6,748
+2,493
| +59% | +$125K | ﹤0.01% | 1575 |
|
|
2021
Q2 | $268K | Buy |
4,255
+916
| +27% | +$57.7K | ﹤0.01% | 1671 |
|
|
2021
Q1 | $310K | Sell |
3,339
-1,254
| -27% | -$116K | ﹤0.01% | 1498 |
|
|
2020
Q4 | $412K | Buy |
4,593
+319
| +7% | +$28.6K | ﹤0.01% | 1257 |
|
|
2020
Q3 | $442K | Buy |
4,274
+675
| +19% | +$69.8K | 0.01% | 1098 |
|
|
2020
Q2 | $285K | Buy |
+3,599
| New | +$285K | ﹤0.01% | 1237 |
|
|
2019
Q2 | – | Sell |
-4,030
| Closed | -$204K | – | 1609 |
|
|
2019
Q1 | $204K | Buy |
4,030
+434
| +12% | +$22K | ﹤0.01% | 1478 |
|
|
2018
Q4 | $213K | Buy |
+3,596
| New | +$213K | ﹤0.01% | 1344 |
|